Details about PDA

Reading File

Finding Sources

Searching PubMed

"patent ductus arteriosus"[MeSH Terms] AND treatment

Reading File

Loading Image

Reading File

I now have comprehensive information from multiple authoritative sources. Here is the full, detailed answer:

Patent Ductus Arteriosus (PDA)

Definition & Anatomy

The ductus arteriosus is a fetal vascular channel derived from the sixth aortic arch. It connects the main (or left) pulmonary artery to the upper descending thoracic aorta, just distal to the origin of the left subclavian artery. In fetal life, it carries about 60% of combined ventricular output, directing blood from the pulmonary artery to the aorta, bypassing the unexpanded, high-resistance lungs.

A PDA occurs when this channel fails to close after birth. The ductal lumen may range from 2-8 mm in length and 4-12 mm in diameter.

Schwartz's Principles of Surgery, 11th Ed. - SCHWARTZ'S PRINCIPLES OF SURGERY 2-volume Set 11th Edition
Robbins & Kumar Basic Pathology - Robbins & Kumar Basic Pathology

Normal Ductal Closure

After birth, several mechanisms drive closure:

Factor	Role
Rising arterial O2 tension	Primary stimulus for smooth muscle contraction
Decreased PGE2 / PGI2	Placenta (major source) is removed; increased pulmonary blood flow metabolizes these prostaglandins
Histamines, catecholamines, bradykinin, acetylcholine	Promote ductal contraction

Functional closure occurs within 10-15 hours postnatally. Complete anatomic obliteration by fibrosis produces the ligamentum arteriosum within the first few months.

Why PDA Persists - Pathogenesis

Cause	Mechanism
Prematurity	Ductal smooth muscle immaturity; low O2 levels
Hypoxia / high altitude	Decreased oxygen tension prevents contraction
Respiratory distress syndrome	Surfactant deficiency → hypoxia → PDA
Maternal rubella infection	Teratogenic damage to ductal tissue
Chromosomal anomalies	Associated with complex CHD
TGF-β failure (proposed)	Failure of post-birth TGF-β induction

Incidence: ~1 in 2000 births overall. In premature infants, up to 75% of infants born at 28-30 weeks have PDA. Female predominance: 2:1 ratio.

Virtually all preterm neonates ≤28 weeks with birth weight <1750 g have PDA in the first 24 hours of life.

The Developing Human - Clinically Oriented Embryology

Pathophysiology & Hemodynamics

Since aortic pressure exceeds pulmonary artery pressure after birth, blood flows left-to-right (aorta → pulmonary artery) continuously throughout the cardiac cycle.

Consequences depend on ductus size:

PDA Size	Hemodynamic Effect	Clinical Result
Small	Minimal shunt, no LV dilation	Asymptomatic; murmur only; risk of endarteritis ~0.45%/year
Moderate/Large (restrictive)	Significant L→R shunt; LV/LA dilation; variable PH	Dyspnea, palpitations, exercise intolerance by 2nd-3rd decade
Large (non-restrictive)	Massive L→R; pulmonary hypertension develops	May progress to Eisenmenger syndrome

The diastolic runoff lowers aortic diastolic pressure → widened pulse pressure and bounding pulses. Left ventricular volume overload leads to tachycardia, tachypnea, and ventricular hypertrophy. By the 4th decade, mortality rises to 3-4%/year, with two-thirds of patients dying by age 60 if untreated.

Eisenmenger syndrome (reversal to right-to-left shunt) develops in ~5% of isolated PDA cases. When this occurs, deoxygenated blood from the pulmonary artery enters the descending aorta, causing differential cyanosis and clubbing - more prominent in the toes than the fingers.

Goldman-Cecil Medicine, International Edition

Clinical Features

Symptoms

Small PDA: asymptomatic
Large PDA: dyspnea, palpitations, exercise intolerance, respiratory infections, CHF

Signs

Widened pulse pressure, bounding peripheral pulses
Hyperactive/hyperdynamic precordium
Classic "machinery murmur" (continuous, systolic + diastolic) heard best at the 1st-2nd left intercostal space below the left clavicle
As pulmonary pressure rises, the diastolic component shortens; in Eisenmenger physiology, the murmur may disappear entirely

Investigations

Test	Findings
CXR	Increased pulmonary vascularity, cardiomegaly (see image below)
ECG	LV strain, left atrial enlargement, possible RV hypertrophy
Echocardiography	Gold standard - demonstrates ductal patency and estimates shunt size with color Doppler
Cardiac catheterization	Reserved for cases with suspected pulmonary hypertension
CMR	Useful in older patients to visualize and quantify shunt

Chest X-ray - Before and After PDA Ligation:

Left: Pre-ligation with increased pulmonary vascularity. Right: Post-ligation showing the surgical clip (★) and clearing of lung fields.

Treatment

The presence of a persistent PDA is sufficient indication for closure due to increased mortality and endocarditis risk (except in Eisenmenger physiology where closure does not help and carries higher mortality).

1. Pharmacological (Premature infants)

Indomethacin or Ibuprofen (COX inhibitors → decrease PGE2 → promote ductal constriction)
Indicated in premature infants
Contraindications: necrotizing enterocolitis, renal insufficiency
Term infants are generally unresponsive to pharmacological therapy

2. Catheter-Based (Transcatheter) Closure

Devices: Rashkind double-umbrella, Gianturco coils, or Amplatzer-type occluders
Widely used; suitable for older patients (>5 years) and smaller ducts (<3 mm)
Complications: thromboembolism, incomplete occlusion, vascular injury, endocarditis, hemorrhage
May not be applicable in very young/small infants (inadequate vascular access)

3. Surgical Closure

Approaches:

Muscle-sparing posterolateral thoracotomy (3rd or 4th intercostal space, left side) - standard approach
Median sternotomy - if additional cardiac lesions require simultaneous repair
Video-assisted thoracoscopic (VATS) clipping - also described

Techniques:

Simple ligation with surgical clip or permanent suture (neonates)
Division between vascular clamps with oversewing of both ends (for short, broad ductus)
CPB may be needed in extreme cases
Recurrent laryngeal nerve must be carefully protected - it courses around the PDA

Preterm newborns and children do well with surgery; older patients and those with ducts <3 mm generally do well with coil occlusion.

Natural History & Prognosis

Estimated 30% death rate for untreated isolated PDA
Leading cause of death: congestive heart failure; secondary cause: respiratory infection
Small PDA: risk of infectious endarteritis ~0.45%/year after the 2nd decade
Large PDA: mortality rises to 3-4%/year by the 4th decade
Two-thirds of patients die by age 60 if untreated with a moderate-large duct

Summary Table

Feature	Detail
Origin	Left 6th aortic arch
Connects	Left pulmonary artery → descending aorta (distal to left subclavian)
Incidence	1/2000 births; 7% of all CHD
Sex	Female > Male (2:1)
Shunt direction	Left-to-right (aorta → pulmonary artery)
Key murmur	Continuous "machinery" murmur, left 1st-2nd ICS
Pharmacotherapy	Indomethacin/Ibuprofen (premature only)
Definitive treatment	Catheter-based closure or surgical ligation
Closure mechanism	Ligamentum arteriosum (fibrous remnant)

Sources: Schwartz's Principles of Surgery (11th Ed.) | Goldman-Cecil Medicine | Robbins & Kumar Basic Pathology | The Developing Human - Clinically Oriented Embryology | Grainger & Allison's Diagnostic Radiology

For a neonatal presentation

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Searching PubMed

"patent ductus arteriosus"[MeSH Terms] AND "infant, premature"[MeSH Terms]

Finding Sources

Reading File

I now have comprehensive neonatal-specific data from multiple authoritative sources. Here is the focused neonatal presentation:

PDA - Neonatal Presentation

Why PDAs Are So Common in Neonates

The neonatal PDA is a fundamentally different clinical entity from PDA in older children or adults. The key driver is prematurity:

Gestational Age	PDA Incidence
Term infants	0.3-0.8% (1 in ~2000)
Premature infants (all)	>20%
≤28 weeks, birth weight <1750 g	~100% within first 24 hours
28-30 weeks gestation	Up to 75%

Why prematurity causes PDA: The ductal smooth muscle is immature, meaning it has impaired sensitivity to the rising oxygen tension that normally drives constriction. As the fetus approaches term, the ductus becomes progressively less sensitive to prostaglandins and more sensitive to oxygen. Preterm infants lack this maturation.

Additional neonatal-specific risk factors:

Respiratory distress syndrome (RDS): Surfactant deficiency → hypoxia → PDA persists. Low oxygen tension is a potent vasodilator of ductal smooth muscle.
Maternal rubella infection (teratogenic damage to ductal tissue)
High altitude births (chronic hypoxia)
Indomethacin used as tocolytic in preterm labor - can cause paradoxical premature ductal constriction in utero, complicating postnatal physiology

Normal ductal closure in a healthy term neonate: functional closure within 10-15 hours, complete anatomic obliteration within weeks.

Mulholland and Greenfield's Surgery, 7e | The Developing Human - Clinically Oriented Embryology

Definition in the Neonate (Harriet Lane)

Failure of the ductus arteriosus to close within the first 72 hours of life, or reopening after functional closure.

Neonatal Pathophysiology

At birth, pulmonary vascular resistance (PVR) drops dramatically and continues to fall over the first weeks. This means:

Any ductal patency → left-to-right shunt (aorta → pulmonary artery)
The shunt increases as PVR falls over weeks
If PVR remains high (as in severe RDS or persistent pulmonary hypertension), shunting may be right-to-left → causing hypoxemia

Consequence of a significant L→R shunt in a neonate:

Pulmonary overcirculation → pulmonary edema, impaired gas exchange, worsening respiratory failure
Left heart volume overload → LV dilation, CHF
Systemic steal ("ductal steal") → decreased diastolic perfusion of vital organs - brain, gut, kidneys
Worsens and prolongs the need for mechanical ventilation

Clinical Presentation in the Neonate

Symptoms

Finding	Mechanism
Tachypnea, respiratory distress	Pulmonary overcirculation + edema
Poor feeding, fatigue	Reduced cardiac output
Failure to thrive	Increased metabolic demand, poor feeding
Difficulty weaning from ventilator	PDA worsens lung disease of prematurity
Apnea	Seen with significant shunting in premature neonates

Signs on Examination

Sign	Detail
Murmur	Initially systolic; may become continuous ("machinery") with L→R flow - heard best at left upper sternal border / left infraclavicular area
Bounding/palmar pulses	Wide pulse pressure from diastolic runoff
Hyperactive precordium	Volume overload of LV
Widened pulse pressure	Diastolic BP falls as blood is shunted into pulmonary circulation
Tachycardia	Sympathetic activation

Important: In premature neonates with high PVR (e.g., severe RDS), the murmur may be absent or only systolic early on - clinical suspicion must remain high even without a classical murmur.

Investigations

Test	Neonatal Findings
Echocardiogram (Echo)	Gold standard - directly visualizes the ductus, color Doppler confirms L→R flow, assesses shunt size, LV dimensions, pulmonary pressure
CXR	Cardiomegaly, increased pulmonary vascular markings (may be hard to distinguish from RDS infiltrates in preterm lungs)
ECG	Normal to moderate LVH in small-moderate PDA; biventricular hypertrophy in large PDA
SpO2 monitoring	If right-to-left shunting: lower saturation in lower extremities vs. right hand (pre-ductal)

Echocardiogram of PDA - color Doppler confirms flow from aorta (AO) into pulmonary artery (PA):

Transesophageal echocardiographic image of a PDA showing flow from the descending aorta into the pulmonary artery by color Doppler

Treatment in the Neonate

Key principle: In premature neonates, pharmacological therapy works. In term neonates, it generally does not (ductal smooth muscle is already mature and unresponsive to PG inhibition).

Step 1 - Conservative / Watchful Waiting

Fluid restriction, diuretics
Some PDAs in premature infants close spontaneously - indications for treatment and timing remain controversial
Harriet Lane Handbook, 23rd Ed.

Step 2 - Pharmacological Closure (Premature infants only)

Drug	Mechanism	Notes
Ibuprofen	COX inhibitor → ↓ PGE2 → ductal constriction	Drug of choice - fewer renal side effects than indomethacin, no increased NEC risk
Indomethacin	COX inhibitor	Effective but more side effects (renal, GI perforations)
Acetaminophen	Emerging alternative (inhibits prostaglandin peroxidase)	Similar efficacy to oral ibuprofen; fewer effects on kidneys and platelets; evidence still evolving

Efficacy: Pharmacologic closure is effective in ~65% of premature infants

Contraindications to NSAIDs (indomethacin/ibuprofen):

Necrotizing enterocolitis (NEC)
Renal insufficiency / oliguria
Intracranial hemorrhage
Bleeding disorders / thrombocytopenia
Sepsis

Complications of NSAIDs in neonates:

Renal: Transient ↓ GFR, oliguria
GI: Transient GI bleeding; spontaneous intestinal perforations (SIPs) with indomethacin (worse with concomitant hydrocortisone)
Haematological: Prolonged bleeding time, impaired platelet function for 7-9 days (not dose-related)

After 3 complete courses of ibuprofen without closure → refer for endovascular or surgical closure.

Step 3 - Transcatheter (Endovascular) Closure

Amplatzer Piccolo Occluder (Abbott): FDA-approved for infants <2 kg
- Procedural mortality: ~3%
- Complete ductal closure: >90%
Other devices: Rashkind double-umbrella, Gianturco coils
Now the treatment of choice for most PDAs

Step 4 - Surgical Ligation

Approach in premature neonates:

Left posterolateral thoracotomy via 3rd intercostal space
Single surgical clip applied to the ductus (ductal tissue is extremely friable in premature infants - direct manipulation is minimized)
Commonly performed at the bedside in the NICU to avoid the hazards of patient transfer

Surgical complications to watch for:

Recurrent laryngeal nerve injury (nerve loops around the ductus)
Phrenic nerve injury
Pneumothorax
Chylothorax (thoracic duct injury)

Note: The ductus may be the largest vascular structure visible in a premature infant - it must not be confused with the aorta.

Surgical closure is now reserved for large-diameter or very short PDAs not amenable to device closure. Periprocedural mortality approaches zero in modern centres.

Mulholland and Greenfield's Surgery, 7e | Harriet Lane Handbook, 23rd Ed. (Johns Hopkins)

Special Scenario - PDA as a Life-Saving Connection

In certain complex CHDs, ductal patency is essential to maintain perfusion until definitive repair:

Defect	Role of PDA
Pulmonary atresia / critical PS	PDA provides the only source of pulmonary blood flow
Severe coarctation / interrupted aortic arch	PDA provides systemic perfusion to the lower body
Hypoplastic left heart syndrome (HLHS)	PDA essential for systemic output

Treatment: IV Prostaglandin E1 (alprostadil/PGE1) is infused to maintain/reopen the ductus in these duct-dependent lesions until surgical palliation (e.g., Norwood procedure) or balloon intervention.

Neonatal PDA - Management Summary

Premature neonate with suspected PDA
        ↓
Echo confirmation
        ↓
Haemodynamically significant?
    YES                    NO
     ↓                      ↓
Check contraindications  Watchful waiting
to NSAIDs
     ↓
Ibuprofen (drug of choice) x 3 courses
  OR Indomethacin / Acetaminophen
     ↓
Closed (~65%)?    Still open?
    ↓                   ↓
Monitor      Transcatheter closure
             (Piccolo Occluder if <2kg)
                   ↓
             Still open / not suitable?
                   ↓
             Surgical ligation (NICU bedside)

Sources: Mulholland and Greenfield's Surgery (7e) | Harriet Lane Handbook (23rd Ed., Johns Hopkins) | Schwartz's Principles of Surgery (11th Ed.) | The Developing Human - Clinically Oriented Embryology

This is a shared conversation. Sign in to Orris to start your own chat.